Globe Life (NYSE:GL) Issues FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 14.950-15.650 for the period, compared to the consensus earnings per share estimate of 15.030. The company issued revenue guidance of -.

Globe Life Price Performance

Shares of Globe Life stock traded up $1.14 on Wednesday, hitting $144.79. 797,458 shares of the company were exchanged, compared to its average volume of 481,227. Globe Life has a 1-year low of $109.38 and a 1-year high of $147.83. The stock has a market capitalization of $11.53 billion, a price-to-earnings ratio of 10.49 and a beta of 0.47. The company has a 50-day moving average price of $138.89 and a 200 day moving average price of $137.73. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.36% and a return on equity of 21.81%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the business earned $3.14 earnings per share. Globe Life’s revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts predict that Globe Life will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Monday, January 5th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Monday, January 5th. Globe Life’s payout ratio is presently 7.83%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on GL shares. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Wells Fargo & Company reduced their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Truist Financial lifted their price target on Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Morgan Stanley reissued an “overweight” rating and set a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Finally, Weiss Ratings cut shares of Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, January 14th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $166.22.

Insider Buying and Selling at Globe Life

In related news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,036,943.24. This trade represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.51% of the company’s stock.

Globe Life News Roundup

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Quarterly operating results improved year-over-year — net operating income was $3.39 per diluted share (up from $3.14 a year ago) and net income rose to $3.29 vs. $3.01 — showing underlying business strength. Read More.
• Positive Sentiment: Profitability metrics remain strong (net margin ~19.4% and ROE ~21.8%), supporting free cash flow/return potential for shareholders. Read More.
• Neutral Sentiment: Management set FY‑2026 EPS guidance at $14.95–$15.65, which is close to analyst consensus (roughly $15.03) — guidance is largely in line but leaves limited upside versus expectations. Read More.
• Neutral Sentiment: Local and college-sports placements of the Globe Life name (games moved to Globe Life Field; articles about teams using the stadium) provide brand exposure but are unlikely to materially affect near-term financials. Read More. Read More.
• Negative Sentiment: Reported EPS of $3.39 missed the consensus by $0.05, and revenue of $1.52B was about $10M below estimates — the modest misses are the main driver of short‑term downside risk. Read More.
• Negative Sentiment: Coverage noted sales below analyst estimates, which could temper analyst revisions or near‑term sentiment if revenue growth concerns persist. Read More.

Institutional Trading of Globe Life

Hedge funds have recently bought and sold shares of the company. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life during the 2nd quarter worth about $28,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the second quarter worth about $31,000. Banque Cantonale Vaudoise bought a new stake in shares of Globe Life during the third quarter valued at approximately $50,000. Advisory Services Network LLC acquired a new stake in shares of Globe Life during the 3rd quarter valued at about $72,000. Finally, Johnson Financial Group Inc. grew its position in Globe Life by 272.6% in the third quarter. Johnson Financial Group Inc. now owns 734 shares of the company’s stock valued at $105,000 after acquiring an additional 537 shares during the period. 81.61% of the stock is currently owned by institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.